Kiki Patel
Gilman Martin Group
Replay available
Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) Q4 2023 earnings conference call, held 2024-03-20. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Talat Imran
Chief Executive Officer
Arvinder Dalla
VP of Clinical Development
Savai Sanford
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Rani Therapeutics Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.100 -- 00:00:05.384 Welcome to the Rani Therapeutics fourth quarter and full year 2023 financial 00:00:05.384 -- 00:00:07.926 results and corporate update conference call. 00:00:07.926 -- 00:00:11.469 At this time, all participants are in a listen-only mode. 00:00:11.469 -- 00:00:15.933 Following management's prepared remarks, we will hold a Q&A session. 00:00:15.933 -- 00:00:20.356 To ensure that we have ample time to address everyone's questions during the Q&A session, 00:00:20.356 -- 00:00:25.280 we would ask for a limit of one question and one follow-up, question per person. 00:00:25.280 -- 00:00:30.453 To ask a question at the time, please press star followed by 11 on your touch tone phone. 00:00:30.453 -- 00:00:36.475 As a reminder, this call is being recorded today, Wednesday, March 20th, 2024. 00:00:36.475 -- 00:00:41.497 I would now like to turn the conference call over to Kiki Patel at Gil Martin Group. 00:00:41.497 -- 00:00:44.017 Please go ahead. 00:00:49.060 -- 00:00:50.520 Thank you, operator. 00:00:50.520 -- 00:00:55.422 Joining us on the call today from Ronnie Therapeutics, our Chief Executive Officer, Talat 00:00:55.422 -- 00:01:00.680 Imran, VP of Clinical Development, Arvinder Dulla, and Chief Financial Officer, Svay 00:01:00.680 -- 00:01:05.563 Sanford. During this conference call, management will make forward-looking statements 00:01:05.563 -- 00:01:10.046 that are subject to risks, uncertainties, and assumptions, such as, but not limited to 00:01:10.046 -- 00:01:14.549 those discussed in the risk factors section of the company's filings with the Securities 00:01:14.549 -- 00:01:19.633 and Exchange Commission, including its annual report on Form 10-K and quarterly 00:01:19.633 -- 00:01:24.916 reports on Form 10-Q, which identify t...